Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letters to the Editor
  • Published:

Importance of anti-HIV-1 antibodies

Nature Medicine volume 3, pages 590–591 (1997)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Parren, P.W.H.I., Burton, D.R. & Sattenau, Q.J. HIV-1 antibody — debris or virion? Nature Medicine 3, 336 (1997).

    Google Scholar 

  2. Karpas, A. et al. Lytic infection by British AIDS virus and the development of rapid cell test for antiviral antibodies. Lancet ii 695–697 (1985).

    Article  Google Scholar 

  3. Karpas, A. et al. Effect of passive immunization in patients with acquired immunodeficiency syndrome — related complex and acquired immunodeficiency syndrome Proc. Natl. Acad. Sci. USA 85, 9234–9237 (1988).

    Article  CAS  Google Scholar 

  4. Karpas, A. et al. Polymerase chain reaction evidence for immunodeficiency virus-1 neutralization by passive immunization in patients with AIDS and AIDS-related complex. Proc. Natl. Acad. Sci. USA 87, 1195–1199 (1990).

    Article  Google Scholar 

  5. Vittecoq, A. et al. Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma. Inf. Diseases 265 364–368 (1992).

    Article  Google Scholar 

  6. Levy, J. et al. Passive hyperimmune therapy in the treatment of AIDS: Results of a multicenter double-blind controlled trial. Blood, 265 2130–2135 (1992).

    Google Scholar 

  7. Vittecoq, D. et al. Passive immunotherapy in AIDS. A double-blind randomized study based on transfusions of plasma rich in anti human immunodeficiency virus 1 antibodies versus transfusions of seronegative plasma. Blood. 265 2130–2135 (1992).

    Google Scholar 

  8. Blick, G. et al. Passive immunotherapy in advanced HIV infection and therapeutic plasmaphoresis in asymptomatic HIV-positive individuals: A four-year clinical experience. Biother. (in the press).

  9. Cao, Y. et al. Virologic and immunologic characterization of long term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332 201–208 (1995).

    Article  CAS  Google Scholar 

  10. Pantaleo, G. et al. studies in subjects with long term non-progressive human immunodeficiency virus infection. N. Engl. J. Med. 332 209–216 (1995).

    Article  CAS  Google Scholar 

  11. Jacobson, J.M. et al. Passive Immunotherapy in treatment of advanced human immunodeficiency virus infection - Reply. J. Infect. Dis. 170 743–744 (1994).

    Article  Google Scholar 

  12. Lambert, J.S. et al. Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. J. Infect. Dis. 175 283–291 (1997).

    Article  CAS  Google Scholar 

  13. Montefiori, D.C. et al. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long term non-progressors. J. Infect. Dis. 173 60–67 (1996).

    Article  CAS  Google Scholar 

  14. Harrer, T. et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retroviruses. 12 585–592 (1996).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department ofHaematology, Cambridge University Clinical School, MRC Centre, Hills Road, Cambridge, CB2 2QH, UK

    Abraham Karpas

  2. Baling Hospital, London, UB1 3HW, UK

    Stephen Ash

  3. Royal London Hospital, London, UK

    Douglas Bainbridge

Authors
  1. Abraham Karpas
    View author publications

    Search author on:PubMed Google Scholar

  2. Stephen Ash
    View author publications

    Search author on:PubMed Google Scholar

  3. Douglas Bainbridge
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karpas, A., Ash, S. & Bainbridge, D. Importance of anti-HIV-1 antibodies. Nat Med 3, 590–591 (1997). https://doi.org/10.1038/nm0697-590c

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0697-590c

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing